Your browser doesn't support javascript.
loading
Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A.
Gonzalez-Menendez, Pedro; Phadke, Ira; Olive, Meagan E; Joly, Axel; Papoin, Julien; Yan, Hongxia; Galtier, Jérémy; Platon, Jessica; Kang, Sun Woo Sophie; McGraw, Kathy L; Daumur, Marie; Pouzolles, Marie; Kondo, Taisuke; Boireau, Stéphanie; Paul, Franciane; Young, David J; Lamure, Sylvain; Mirmira, Raghavendra G; Narla, Anupama; Cartron, Guillaume; Dunbar, Cynthia E; Boyer-Clavel, Myriam; Porat-Shliom, Natalie; Dardalhon, Valérie; Zimmermann, Valérie S; Sitbon, Marc; Dever, Thomas E; Mohandas, Narla; Da Costa, Lydie; Udeshi, Namrata D; Blanc, Lionel; Kinet, Sandrina; Taylor, Naomi.
Afiliación
  • Gonzalez-Menendez P; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
  • Phadke I; Laboratory of Excellence GR-Ex, Paris, France.
  • Olive ME; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
  • Joly A; Laboratory of Excellence GR-Ex, Paris, France.
  • Papoin J; Pediatric Oncology Branch, National Cancer Institute (NCI), Center for Cancer Research (CCR), National Institutes of Health (NIH), Bethesda, MD.
  • Yan H; Proteomics Platform, Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA.
  • Galtier J; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
  • Platon J; Laboratory of Excellence GR-Ex, Paris, France.
  • Kang SWS; Feinstein Institute for Medical Research, Manhasset, NY.
  • McGraw KL; EA4666 HEMATIM, Université Picardie Jules Verne, Amiens, France.
  • Daumur M; New York Blood Center, New York, NY.
  • Pouzolles M; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
  • Kondo T; Laboratory of Excellence GR-Ex, Paris, France.
  • Boireau S; EA4666 HEMATIM, Université Picardie Jules Verne, Amiens, France.
  • Paul F; Thoracic and GI Malignancies Branch, NCI, CCR, NIH, Bethesda, MD.
  • Young DJ; Laboratory of Receptor Biology and Gene Expression, NCI, CCR, NIH, Bethesda, MD.
  • Lamure S; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
  • Mirmira RG; Laboratory of Excellence GR-Ex, Paris, France.
  • Narla A; Pediatric Oncology Branch, National Cancer Institute (NCI), Center for Cancer Research (CCR), National Institutes of Health (NIH), Bethesda, MD.
  • Cartron G; Pediatric Oncology Branch, National Cancer Institute (NCI), Center for Cancer Research (CCR), National Institutes of Health (NIH), Bethesda, MD.
  • Dunbar CE; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
  • Boyer-Clavel M; Montpellier Ressources Imagerie, BioCampus, University of Montpellier, CNRS, INSERM, Montpellier, France.
  • Porat-Shliom N; Department of Clinical Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Dardalhon V; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD.
  • Zimmermann VS; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
  • Sitbon M; Department of Clinical Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Dever TE; Department of Medicine, The University of Chicago, Chicago, IL.
  • Mohandas N; Division of Pediatric Hematology/Oncology, Stanford University, Stanford, CA.
  • Da Costa L; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
  • Udeshi ND; Department of Clinical Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Blanc L; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD.
  • Kinet S; Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
  • Taylor N; Thoracic and GI Malignancies Branch, NCI, CCR, NIH, Bethesda, MD.
Blood ; 141(20): 2520-2536, 2023 05 18.
Article en En | MEDLINE | ID: mdl-36735910
ABSTRACT
Metabolic programs contribute to hematopoietic stem and progenitor cell (HSPC) fate, but it is not known whether the metabolic regulation of protein synthesis controls HSPC differentiation. Here, we show that SLC7A1/cationic amino acid transporter 1-dependent arginine uptake and its catabolism to the polyamine spermidine control human erythroid specification of HSPCs via the activation of the eukaryotic translation initiation factor 5A (eIF5A). eIF5A activity is dependent on its hypusination, a posttranslational modification resulting from the conjugation of the aminobutyl moiety of spermidine to lysine. Notably, attenuation of hypusine synthesis in erythroid progenitors, by the inhibition of deoxyhypusine synthase, abrogates erythropoiesis but not myeloid cell differentiation. Proteomic profiling reveals mitochondrial translation to be a critical target of hypusinated eIF5A, and accordingly, progenitors with decreased hypusine activity exhibit diminished oxidative phosphorylation. This affected pathway is critical for eIF5A-regulated erythropoiesis, as interventions augmenting mitochondrial function partially rescue human erythropoiesis under conditions of attenuated hypusination. Levels of mitochondrial ribosomal proteins (RPs) were especially sensitive to the loss of hypusine, and we find that the ineffective erythropoiesis linked to haploinsufficiency of RPS14 in chromosome 5q deletions in myelodysplastic syndrome is associated with a diminished pool of hypusinated eIF5A. Moreover, patients with RPL11-haploinsufficient Diamond-Blackfan anemia as well as CD34+ progenitors with downregulated RPL11 exhibit a markedly decreased hypusination in erythroid progenitors, concomitant with a loss of mitochondrial metabolism. Thus, eIF5A-dependent protein synthesis regulates human erythropoiesis, and our data reveal a novel role for RPs in controlling eIF5A hypusination in HSPCs, synchronizing mitochondrial metabolism with erythroid differentiation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Espermidina / Proteómica Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Espermidina / Proteómica Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Francia